DHA:RENATA (Bangladesh)  
Renata Ltd logo

Renata Ltd

BDT 1303.20 (0%) Sep 29
P/E:
25.23
P/B:
4.92
Market Cap:
BDT 139.69B ($ 1.40B)
Enterprise V:
BDT 143.57B ($ 1.43B)
Volume:
2.46K
Avg Vol (2M):
12.66K
Volume:
2.46K
Market Cap BDT:
139.69B
Market Cap $:
1.40B
PE Ratio:
25.23
Avg Vol (2-Month):
12.66K
Enterprise Value BDT:
143.57B
Enterprise Value $:
1.43B
PB Ratio:
4.92
GF Score:
Year:
Embed
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website Sources Stock Report
Dataset
Financial Download

Business Description

Description
Renata Ltd is a Bangladesh based pharmaceutical company. It is primarily engaged in the manufacturing, marketing, and distribution of Human Pharmaceuticals, Animal Health Medicines, Nutritionals, and Vaccines. It manufactures various pharmaceutical products including Beconex Zi Syrup, Cabolin Tablet, Flontin Tablet, Ivana Tablet, and others. Some of the animal health products offered by the company are Doxivet Powder, Fevenil Injection, Diadin Bolus, Renamet Tablet, and others. The company operates in Bangladesh and sells its products locally and internationally.
Name Current Vs Industry Vs History
Cash-To-Debt 0.45
Equity-to-Asset 0.72
Debt-to-Equity 0.25
Debt-to-EBITDA 0.84
Interest Coverage 39.28
Piotroski F-Score 7/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 9.99
Distress
Grey
Safe
Beneish M-Score 0
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 39.07
9-Day RSI 43.02
14-Day RSI 44.21
6-1 Month Momentum % -2.67
12-1 Month Momentum % -0.39

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.66
Quick Ratio 0.88
Cash Ratio 0.32
Days Inventory 152.15
Days Sales Outstanding 37.44
Days Payable 8.91

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:
Embed

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil BDT) 32,064.406
EPS (TTM) (BDT) 51.658
Beta 0
Volatility % 5.29
14-Day RSI 44.21
14-Day ATR (BDT) 4.001869
20-Day SMA (BDT) 1304.65
12-1 Month Momentum % -0.39
52-Week Range (BDT) 1282 - 1380
Shares Outstanding (Mil) 107.19

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 7
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Renata Ltd Filings

Document Form Filing Date
No Filing Data

Renata Ltd Analysis

Share your research